showed that gene therapy can eliminate rabies from the infected neurons by using rAAV-N796. To fight 21 rabies virus, induced pluripotent cells in combination with CRISPR/Cas9 system can also be beneficial.
Introduction

27
Rabies is one of the oldest diseases on the globe and most feared zoonotic disease known to 28 humankind. The disease is hazardous, progressive and practically deadly encephalomyelitis [1] .
29
Lissavirus is the most important rabies virus (RABV) [2] . Rabies can infect both humans and domestic 30 animals. Most cases of rabies in animals arise among bats, carnivores, cats, raccoons, [3] , mongooses, and 31 wolves [4] . In addition, a natural rabies infection in birds has also been reported [5] . Dog (Canis lupus 32 familiaris) [6, 7] is the source of more than 99% of rabies cases in humans. [8, 9] .
33
Animal transmits RABV from animal to human through bites, or mucous membranes from saliva 34 [2, 6] or other potentially infectious material such as neural tissue. In domestic animals, the incubation 35 time is normally around 1-3 months. It can range from several days to months, rarely more than 6 months 36 [2] . This incubation time in humans is usually several weeks to more than one year [3] . Non-bite sources 
54
To prevent rabies, billion of dollars are needed. These costs can be greater if the disease is not 
58
A systematic literature review is the heart of this study. This study includes rabies disease,
59
vaccinations, gene therapy, and costs for fighting rabies. The gene therapy is for animal models only.
60
Methods
61
Systematic review
62
The present report follows the instructions of the PRISMA extension statement for systematic 63 review [12] . These instructions also correspond to PROSPERO instructions such as searches and risk of 64 bias assessment [13] . Below, the author quoted items from the PROSPERO written by the author.
of 16
The study included a rabies case kept at the Nelwan Institution for Human Resource 
103
The author screened titles and abstract using the search strategy to identify studies that 
Results
122
The author took 163 articles from the Pubmed Database searches (Figure 1 ). After screening titles 123 and abstract, 128 articles were taken for full-text review. Of these 58 articles met the criteria for data 124 extraction. These studies were included in the main body. 
3.1.A rabies case in Indonesia
126
Forebears of Indonesian RABVs derived from Java. The Java's RABVs offspring transmitted these 127 rabies viruses to Kalimantan, and then to Bali, Flores, and Sumatra. The Flores's offspring transmitted 128 these RABVs viruses to Sulawesi and went back to Kalimantan. In Indonesia, the dog was the only source 129 of infection of other animals [18] .
130
In this study, the dog rabies was a male, and was six years old when he died. He was the only 
Rabies on the globe
136
More than 3.3 billion people worldwide are at risk of being infected by the rabies virus [19] . 
140
(17.65%) showed 55000 human deaths from rabies annually; Table 1 . Furthermore, more than 95% of 141 human deaths due to rabies occur in Asia and Africa [9, 29, 30, 35] . Globally, around 84% of these deaths
of 16
occur in rural areas [1] . Approximately, 50% of human deaths due to rabies are below 15 years old [10, 19, 
197
In Asia, several countries have successfully eradicated rabies (Table 2) 
210
Many countries of Latin America have successfully eradicated rabies, ( Table 4 .
261
The author's did not find any reference relating to iPSCs and CRISPR/Cas9 system for treating 
Estimated burden of rabies in the world
266
The annual cost for rabies prevention varies from region to region, including one country to 
271
The estimated annual cost of rabies is US$ 8. 
Discussion
278
Humans have been living in fear of rabies outbreaks of dogs since thousands of years ago.
279
Currently, more than half the world's population is still fearful of rabies outbreaks. 
305
The PEP is a human condition that has had dog bites. Both dogs and humans who get dog bites 
317
Lavan et al. showed the cost benefit for mass vaccination and human PEP and human PEP only.
318
The costs were based on the annual cost of the rabies project in Bhutan as long as 6 years. 
332
Costs to fight rabies with mass vaccination and PEP is lower than costs of human PEP only. 
340
Conflicts of interests:
The author declares that there are no competing interests.
341
Funding: Professor Martin Nelwan takes the responsibility for initiating the review.
342
Author's contribution: MLN conceived and design of the study, participated in its design, draft the 343 manuscript, and involved in revising the manuscript critically for significant intellectual need. 
